Maria Elizabeth DE SOUZA RODRIGUES,Malu G. TANSEY,Christopher J. BARNUM,Raymond J. TESI
申请号：
US16652407
公开号：
US20200289576A1
申请日:
2018.09.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The disclosure concerns a method of treating complications of acute or chronic hyperglycemia and/or diet-induced obesity comprising: (i) determining whether a patient suffers from complications related to acute or chronic hyperglycemia and/or diet induced obesity, and if so, (ii) administering to the patient in need thereof a selective inhibitor of soluble TNF-α but not transmembrane TNF-α. For purposes herein, complications of acute or chronic hyperglycemia and/or diet-induced obesity include: diabetes mellitus, insulin resistance, hepatic steatosis, non-alcoholic hepatic steatosis, fibrotic liver disease, vascular disease, and chronic intestinal inflammation.
